A phase I, multicenter, open-label, first-in-human study of DS-6157a in patients with advanced gastrointestinal stromal tumor

Authors

Suzanne George, Dana-Farber Cancer Institute
Peter Oppelt, Washington University School of Medicine in St. Louis
et al.

Journal

Clinical Cancer Research

Publication Date

9-15-2023

Volume

29

Issue

18

First Page

3659

Last Page

3667

Document Type

Open Access Publication

DOI

10.1158/1078-0432.CCR-23-0640

Rights and Permissions

George S, Heinrich MC, Somaiah N, Oppelt P, McLeod R, Nishioka S, Kundu MG, Qian X, Kumar P, Laadem A, Lau Y, Tran BP, Fallon M, Dosunmu O, Shi J, Naito Y. A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor. Clin Cancer Res. 2023 Sep 15;29(18):3659-3667. doi: 10.1158/1078-0432.CCR-23-0640. ©2023 The Authors; Published by the American Association for Cancer Research This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

Recommended Citation

George, Suzanne; Oppelt, Peter; and et al., "A phase I, multicenter, open-label, first-in-human study of DS-6157a in patients with advanced gastrointestinal stromal tumor." Clinical Cancer Research. 29, 18. 3659 - 3667. (2023).
https://digitalcommons.wustl.edu/oa_4/3145

Additional Links

Supplemental material is available for this article at publisher site.